Guiding Better Decisions in Compound Design Technologies

Published: 6-Feb-2014

19 March 2014

International Symposium

British Embassy, Tokyo


Cresset, Optibrium, Lhasa Limited and Chemogenomix, providers of computational chemistry software and services, announce this symposium, which will be held in the British Embassy in Tokyo on 19 March and at the British Consulate-General in Osaka on 20 March.

Delegates will hear about technologies that guide them to successful small molecule and biotherapeutic drug discovery and development, intuitive molecular design and 3D-QSAR interpretation as well as knowledge-based toxicity prediction.

Organiser: Cresset Group

www.cresset-group.com/news-events/events/international-symposium-on-compound-design-technologies/

Trending Articles

  1. CPhI North America 7-9 May 2024 | Exhibition | Pennsylvania, US
  2. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  3. ASGCT Annual Meeting 2024 7-11 May, 2024 | Meeting | Portland, OR
  4. CPhI South East Asia 2024 10-12 July 2024 | Exhibition and Conference | Bangkok, Thailand
  5. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany

You may also like

Research & Development

Cresset creates new Vice President role to lead its AI strategy

Dr Mutlu Dogruel joins from Microsoft, where he was responsible for empowering organisations to implement scalable AI solutions into their workflow
Research & Development

Cresset aims to optimise drug discovery with latest drug design platform release

The software will optimise the determination of potent molecules in silico
Research & Development

Cresset targets international growth with Innovate UK Scaleup Programme

Cresset has been accepted onto the Innovate UK Scaleup Programme, which aims to help specially selected businesses with scaling potential realise their commercial ambitions
Research & Development

Cresset signs alliance to speed up drug design

The alliance between British and Chinese companies is intended to speed up drug design
Research & Development

Peakdale signs collaborative agreement with computational chemistry company Cresset

Cresset delivers software and contract research services which help chemists discover, design and optimise the best small molecules for their project
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Maximising discovery success

While the number of drug discovery targets has increased dramatically, unravelling their complex molecular interactions and successfully transforming them into new drugs remains a colossal task. Susan Birks reports on new R&D technology and trends
Research & Development

Domainex and Cresset form drug discovery services alliance

Will provide laboratory-based and computational drug discovery services by combining their capabilities in chemistry and biology
Subscribe now